Proteomic and Bioinformatic Approaches to the Development of Biomarker Signatures of Clinical Utility for Prostate Cancer: From Discovery to Targeted Verification Stephen Pennington, University College Dublin, speaking at Systems Biology Europe 2012
In vivo SILAC-based Proteomics Reveals Phosphoproteome Changes during Skin Carcinogenesis Sara Zanivan, Beatson Institute for Cancer Research, speaking at Systems Biology Europe 2012
Kinase Centric Chemical Proteomics Provides Novel Insights into Individual Cancer Biology Bernhard Kuster, Technical University Munich, speaking at Systems Biology Europe 2012
Next Generation X-Aptamers for Identification of Personalized Biomarkers in Cancer David G. Gorenstein, Ph.D., University of Texas Health Sciences Center, speaking at Genomics Research 2012.
Multi-analyte Procedures for Target Screening and Quantification of Drugs in Blood using LC-MS/MS: Possibilities and Limitations Hans Maurer, Saarland University, speaking at European Lab Automation 2012.
Signalling Molecules as Proteomic Biomarkers in Brain Tumours Radu Albulescu talking on behalf of Cristiana Tanase MD, PhD, Victor Babes University of Medicine and Pharmacy, Timisoara, speaking at Molecular Diagnostics Europe 2012.
Towards a Disease-specific Biomarker Signature for Neuromuscular Disorders Professor Kay Ohlendieck, National University of Ireland, speaking at Molecular Diagnostics Europe 2012.
Too Big for a Small World? Intact Protein Analysis by Nano-UHPLC-MS/MS Mark Parkin, Kings College London, speaking at European Lab Automation 2012
Using Metabolomics to Study Malaria Steven M. Fischer, Agilent Life Sciences Group, speaking at Mass Spec Europe 2011.